Montelukast Prescribing at BROCKLEBANK GROUP PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
477
Total Quantity
15.6K
NHS Cost
£797
vs National Avg
-30.3%
BROCKLEBANK GROUP PRACTICE prescribed 477 items of Montelukast over the last 12 months at a cost of £797 to the NHS. This is 30.3% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
38
Jul 2026
43
Jul 2026
36
Jul 2026
38
Jul 2026
38
Jul 2026
47
Jul 2026
49
Jul 2026
32
Jul 2026
45
Jul 2026
30
Jul 2026
43
Jul 2026
38
Prescribing Details
| Total Items | 477 |
|---|---|
| Total Quantity | 15,603 |
| Total NHS Cost | £797 |
| Presentations | 4 different forms |
| vs National Average | -30.3% |
Montelukast Prescribing Comparison
| This practice | 477 items |
|---|---|
| National average per practice | 685 items |
| Difference | -30.3% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.